Olutasidenib, CAS [[1887014-12-1]]

Produktübersicht

• Artikelname: Olutasidenib, CAS [[1887014-12-1]]
• Artikelnummer: TGM-T16384
• Hersteller Artikelnummer: T16384
• Alternativnummer: TGM-T16384-1MLX10MM(INDMSO),TGM-T16384-1MG,TGM-T16384-5MG,TGM-T16384-10MG,TGM-T16384-25MG,TGM-T16384-50MG,TGM-T16384-100MG,TGM-T16384-200MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: FT-2102

Produktbeschreibung

Olutasidenib (FT-2102) is under the study in the treatment of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Olutasidenib is a highly effective, brain penetrant, and selective inhibitor of the mutant Isocitrate dehydrogenase 1 (IDH1) (IC50: 21.2 nM and 114 nM for IDH1- R132H and IDH1- R132C, respectively).

Produkteigenschaften

• Molekulargewicht: 354.79
• Reinheit: 98.57%
• CAS Nummer: [1887014-12-1]
• Formel: C18H15ClN4O2
• Target-Kategorie: Isocitrate Dehydrogenase (IDH)|||Dehydrogenase

Bilder

T16384